To study the Efficacy of SAUMYADI CHURNA In Essential Hypertention.
Phase 4
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2021/09/036660
- Lead Sponsor
- Hon Shri Annasaheb Dange Ayurvedic Medical College And Post Graduate Research Centre Ashta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Stage 1 hypertension i,e Systolic BP is 140-159 mm of Hg.or Diastolic BP 90-99 mm of hg without any medication.
Exclusion Criteria
Patient who have history of acute CAD, Cardiomyopathy, MI, Stroke.
pregnant and Lactating women.
Patient who have h/o Nephropathy and organ Failure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Study the efficacy of Saumyadi Churna and Tab Amlodipine 5mg in Essential Hypertension.Timepoint: 18 Months
- Secondary Outcome Measures
Name Time Method Characteristic of Saumyadi Churna and Tab Amlodipine 5mg in Essential Hypertension.Timepoint: 18 Months